A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
NiKang Therapeutics, Inc.
Indiana University
Sumitomo Pharma America, Inc.
Aravive, Inc.
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Rexahn Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Oxford
University of Kansas Medical Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)